SIN Viral Vector Amplification for Accurate Copy Number Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for determining viral vector copy number in samples transduced with self-inactivating (SIN) viral vectors, such as lentiviral and gamma-retroviral vectors, are inaccurate due to the inability to distinguish between integrated viral nucleic acids and residual plasmids, leading to overestimation and reduced reproducibility.
Innovation Solution
A method involving PCR-based amplification of a reverse-transcriptase-dependent amplicon specific to reverse-transcribed SIN viral vector nucleic acids, using primers designed for regions like delU3 and PBS, and a probe for the U5 region, allowing accurate quantification through techniques like ddPCR.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional PCR methods are used to detect viral nucleic acid, then amplification of viral sequences is achieved, but plasmid residuals are also amplified causing false positives and overestimation of copy number
Solution Approach 1:
The detection method is segmented into two distinct phases: reverse transcription phase (converting viral RNA to cDNA) and amplification phase (PCR). The primers are designed to specifically amplify only the reverse-transcribed cDNA, not the original plasmid DNA. This segmentation allows selective detection of viral sequences while excluding plasmid residuals from amplification.
Solution Approach 2:
Reverse transcription acts as an intermediary step between viral RNA detection and PCR amplification. By converting viral RNA to cDNA first, the method creates an intermediate form that can be specifically amplified by PCR primers designed for the cDNA sequence, thereby distinguishing viral sequences from plasmid DNA that lacks the reverse-transcribed structure.
2Productivity
If primers target conserved viral regions, then amplification efficiency is improved, but specificity decreases due to cross-reactivity with non-viral sequences
Solution Approach 1:
The primers target a specific local region within the viral genome - the reverse-transcribed cDNA sequence that includes both viral-specific elements and the adapter sequence. This localized targeting provides high specificity because the combination of viral sequence and adapter sequence is unique to reverse-transcribed viral cDNA, while still allowing efficient amplification within this defined region.
3Measurement precision
If amplification conditions are optimized for sensitivity, then detection of low-copy viral sequences is improved, but background noise from plasmid residuals increases
Solution Approach 1:
The method converts the potential harm of plasmid residuals into a benefit by designing the system so that plasmid DNA cannot be reverse transcribed (lacking the appropriate RNA template and adapter sequence), while viral RNA can be efficiently converted to cDNA and amplified. The plasmid residuals become inert background that does not interfere with the specific detection of viral sequences.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides precise and reproducible determination of viral vector copy number by specifically amplifying only reverse-transcribed SIN viral nucleic acids, reducing false positives from plasmid residuals and improving accuracy and precision compared to traditional methods.
Implementation Method 1
The incubating is performed by polymerase chain reaction (PCR)
Implementation Method 2
the method further comprises detecting a signal from the detectable moiety
Data Source
AI summary
Provided herein are methods to amplify reverse-transcriptase dependent viral vector nucleic acid products, methods for determining viral vector copy number, and reagents including primers and probes for use in the methods.